| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$201,782,322 |
|
|
|
Indirect Value
|
$171,213,609 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$372,995,931 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 25 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NEOS |
Neos Therapeutics, Inc. |
10% Owner |
– – • |
2015-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,044,578 |
1,044,578 |
0 |
- |
|
| BIOL |
Biolase Inc |
10% Owner |
– – • |
2015-10-09 |
4 |
B |
$0.95 |
$1,045,000 |
I/I |
1,100,000 |
3,884,666 |
1.5 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-04-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,100,000 |
1,077,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-06-05 |
4 |
B |
$8.58 |
$9,438,000 |
I/I |
1,100,000 |
15,963,997 |
2.25 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2024-01-23 |
4 |
A |
$0.00 |
$0 |
I/I |
1,156,069 |
6,949,694 |
0 |
- |
|
| AWH |
Aspira Womens Health Inc |
10% Owner |
– – • |
2014-12-23 |
4 |
B |
$1.44 |
$1,855,208 |
I/I |
1,288,339 |
1,288,339 |
1.5 |
- |
|
| BIOL |
Biolase Inc |
|
• • • |
2020-02-11 |
4 |
S |
$0.60 |
$784,759 |
I/I |
(1,307,931) |
739,820 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2024-05-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,560,694 |
8,510,388 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
10% Owner |
– – • |
2015-06-19 |
4 |
B |
$3.32 |
$5,527,269 |
D/D |
1,664,840 |
2,185,652 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-11-29 |
4 |
S |
$2.76 |
$4,683,500 |
D/D |
(1,700,000) |
6,087,521 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
10% Owner |
– – • |
2017-12-19 |
4 |
B |
$2.26 |
$4,309,241 |
I/I |
1,906,744 |
3,270,481 |
1.5 |
- |
|
| TTHI |
Transition Therapeutics |
10% Owner |
– – • |
2011-11-22 |
4 |
B |
$1.35 |
$2,600,000 |
D/D |
1,925,926 |
2,823,010 |
2.45 |
- |
|
| AWH |
Aspira Womens Health Inc |
|
• • • |
2020-07-01 |
4 |
B |
$3.50 |
$8,000,003 |
I/I |
2,285,715 |
25,394,517 |
0.01 |
- |
|
| BDSX |
Biodesix Inc |
Director |
– • • |
2021-12-30 |
4 |
B |
$4.35 |
$9,999,998 |
I/I |
2,298,850 |
8,463,164 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-12-15 |
4 |
B |
$17.00 |
$39,999,997 |
I/I |
2,352,941 |
11,238,178 |
2.25 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-10-25 |
4 |
B |
$1.20 |
$3,076,500 |
I/I |
2,563,750 |
6,217,345 |
1.5 |
- |
|
| BDSX |
Biodesix Inc |
Director |
– • • |
2022-04-07 |
4 |
B |
$1.79 |
$5,000,000 |
I/I |
2,793,296 |
11,256,460 |
2.25 |
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2008-02-08 |
4 |
D |
$89.50 |
$251,028,347 |
D/D |
(2,804,786) |
0 |
0 |
- |
|
| AWH |
Aspira Womens Health Inc |
|
• • • |
2018-04-17 |
4 |
B |
$1.00 |
$2,838,090 |
I/I |
2,838,090 |
13,416,342 |
0.01 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2018-12-21 |
4 |
B |
$1.61 |
$4,868,699 |
I/I |
3,031,002 |
4,550,678 |
1.5 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-11-01 |
4 |
B |
$2.80 |
$9,010,000 |
D/D |
3,217,857 |
7,780,721 |
2.45 |
- |
|
| HNSN |
Hansen Medical Inc |
Director |
– • – |
2014-02-26 |
4 |
OE |
$1.23 |
$4,605,236 |
I/I |
3,744,094 |
13,233,640 |
0 |
- |
|
| AWH |
Aspira Womens Health Inc |
|
• • • |
2018-06-21 |
4 |
OE |
$1.00 |
$3,961,900 |
I/I |
3,961,900 |
17,378,242 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-03-31 |
4 |
B |
$0.00 |
$0 |
I/I |
4,000,000 |
7,911,804 |
1.42 |
% |
|
| AWH |
Aspira Womens Health Inc |
10% Owner |
– – • |
2013-12-19 |
4 |
OE |
$1.46 |
$5,920,529 |
D/D |
4,055,157 |
6,673,029 |
0 |
- |
|
634 Records found
|
|
Page 25 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
